In the upside down world of prostate cancer, the good guys want to win the war and the bad guys are leading the resistance. Imagine Rick’s Café in Casablanca, except it’s the bad guys, with a nod from Humphrey Bogart, who are the ones singing “La Marseillaise” – drowning out. Read More
Bacteria, Infection, Inflammation… Cancer? Guess what? Urine’s not sterile! This may be bad news for people like TV survival expert Bear Grylls, who often resorts to drinking his own urine to stay hydrated in the wilderness. But it’s startling and exciting news to scientists, who for years believed that if. Read More
Every year, thousands of men are diagnosed with prostatitis. Some of them might even have it. Most of them don’t. Maybe you’re one of those men, and you’ve been taking antibiotics for weeks because your doctor told you that’s what you had. How are your symptoms? Are they any better?. Read More
Christopher Barbieri, M.D., Ph.D. Assistant Professor, Urology Assistant Professor, Cell and Developmental Biology Weill Cornell Medicine New York Presbyterian Medical Center “There’s no one way to select candidates for active surveillance,” says urologist and molecular biologist Chris Barbieri, M.D., Ph.D., who treats men with all kinds of prostate cancer and. Read More
Is active surveillance right for you? The answer to this question varies, depending on a bunch of factors: your particular form of prostate cancer, your age and general health, and also on the criteria used to select men for active surveillance programs from hospital to hospital. First, what is active. Read More
It wasn’t that great of an idea to start with: giving hormonal therapy to lower testosterone in men with localized prostate cancer to make them eligible for radiation seed treatment. The idea is that a short course of hormonal therapy – usually a shot of Lupron or Zoladex – will. Read More
We may have turned the corner. We’re not there yet, but wow, are we hopeful! At the Prostate Cancer Foundation, our goal has always been to put ourselves out of business by curing this terrible disease. Not just by catching it early, or by curing cancer that’s confined to the. Read More
“African-American men are discriminated against by prostate cancer, and for the first time, we know why.” This was oncologist Jonathan Simons, M.D., CEO of the Prostate Cancer Foundation, talking to the Congressional Black Caucus at a special symposium on prostate cancer. Simons was telling the lawmakers about the trailblazing work. Read More
When it comes to lethal prostate cancer, men of African descent are born with a genetic Achilles heel – or more likely, several points of weakness that make them vulnerable. It’s not all genetic; the deck is stacked against these men for many reasons, including the high-fat, low-vegetable Western diet,. Read More
Men of African descent are more likely to develop prostate cancer, and African American men are more than twice as likely caucasian men to die from it. Although lifestyle habits contribute to this greater likelihood, it is chiefly the result of certain genes that men of African descent possess. Learn. Read More
